Skip to content
Triangle logo TriangleGet started
← Hodgkin Lymphoma

HEALTH PROFESSIONAL · SOURCE READING

Chemotherapy

Source: Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: February 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment Option Overview for HL

Table 4 describes the chemotherapy regimens used in the treatment of HL.

Table 4. Chemotherapy Regimens Used to Treat Hodgkin Lymphoma
Combination NameDrugs IncludedPrognostic Group
HL = Hodgkin lymphoma.
ABVDDoxorubicin, bleomycin, vinblastine, and dacarbazineEarly favorable classic HL
Early unfavorable classic HL
Advanced classic HL
BEACOPPBleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisoneEarly unfavorable classic HL
Advanced classic HL
GVDGemcitabine, vinorelbine, and liposomal doxorubicinRecurrent classic HL
ICEIfosfamide, carboplatin, and etoposideRecurrent classic HL
MOPPMechlorethamine, vincristine, procarbazine, and prednisoneAdvanced classic HL
Source links and citations

Preserved source evidence · Not medical advice